Stock AVDL AVADEL PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Avadel Pharmaceuticals plc

Equities

AVDL

IE00BDGMC594

Market Closed - Nasdaq
Other stock markets
 02:00:01 04/05/2024 am IST 		5-day change 1st Jan Change
18.82 USD +2.84% Intraday chart for Avadel Pharmaceuticals plc +5.61% +29.60%
25/04 European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT
23/04 European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8
AQ
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
AQ
Avadel Pharmaceuticals Issues Statement On Patent Litigation
AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
AQ
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
AQ
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights
AQ
Avadel: Q3 Earnings Snapshot
AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8
AQ
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ for extended-release oral suspension at World Sleep 2023
AQ
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023
AQ
Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro Summit
AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
AQ
Avadel: Q2 Earnings Snapshot
AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
AQ
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVDL Stock
  4. News Avadel Pharmaceuticals plc
  5. Press Releases